Composition for enhancing effect of antibody drug
US12377116B2 · kind B2 · utility
0Cited by
2References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 10, 2020 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Sep 4, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/555
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a composition capable of enhancing the effect of an antibody drug such as an immune checkpoint inhibitor, etc. A β-glucan is used as an active ingredient of a composition for enhancing the effect of an antibody drug. This composition is used suitably for antibody drugs that have an effect of suppressing growth of cancer via immune checkpoint inhibition; e.g., antibody drugs including a monoclonal antibody to PD-L1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.